Open Access · CC BY-NC-ND 4.0
Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan
Iraqi Journal of Hematology · 2026-01 · 15 (1) · 143-143
DOI: 10.4103/ijh.ijh_44_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Hematology, 2026-01. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan. Iraqi Journal of Hematology, 15(1), 143-143. https://doi.org/10.4103/ijh.ijh_44_26
Vancouver
Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan. Iraqi Journal of Hematology. 2026;15(1):143-143. doi:10.4103/ijh.ijh_44_26
BibTeX
@article{euvimed2026,
title = {Erratum: First-line tyrosine kinase inhibitor response in chronic myeloid leukemia: A retrospective study from Iraqi Kurdistan},
journal = {Iraqi Journal of Hematology},
year = {2026},
volume = {15},
number = {1},
pages = {143--143},
doi = {10.4103/ijh.ijh_44_26}
}
EUVIMED